Why Insmed Incorporated (INSM) Stock Rose 15.1% on Oct 29, 2026
What happened
Insmed reported third-quarter 2026 financial results today, posting a net loss but beating revenue estimates (Zacks). The stock surged +15.02% to $111.55, suggesting investors rewarded the top-line beat and business update despite the loss.
Management's commentary on profitability timeline and updated full-year 2026 guidance in the earnings call or 8-K filing.
Other developments that session
Insmed Incorporated (INSM) reported EPS of −$0.46 vs. consensus estimate of −$0.38 for Q3 FY2026 on October 29, 2026, missing consensus by 20.1%.
Insmed Incorporated (INSM) filed its 10-Q on 2026-10-29.
INSM reported Q3 EPS loss of $0.46, missing consensus estimate of $0.34 but improving year-over-year from $1.75 loss.
Frequently asked questions
Why did Insmed Incorporated (INSM) stock rise on Oct 29, 2026?
Insmed reported third-quarter 2026 financial results today, posting a net loss but beating revenue estimates (Zacks). The stock surged +15.02% to $111.55, suggesting investors rewarded the top-line beat and business update despite the loss.
How much did INSM stock rise on Oct 29, 2026?
INSM rose 15.1% during the Oct 29, 2026 trading session.